Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance

Figure 1

Molecular analysis of Escherichia coli isolates from cohort patients. A. ERIC2-PCR profiles of Escherichia coli isolates. Lanes 1 and 23: 1 Kb plus molecular size marker; Lanes 2–20: clinical isolates; Lanes 21 and 22: control strains ST69 and ATCC25922. B. Dendrogram of ERIC-2 PCR profiles of Escherichia coli isolates. C: control isolates.

Back to article page